
EFFICACY AND SAFETY OF OLMESARTAN MEDOXOMIL (OM)+AMLODIPINE BESYLATE (AML)+HYDROCHLOROTHIAZIDE (HCTZ) IN PATIENTS WITH HYPERTENSION ANALYZED BY AGE AND GENDER: THE TRINITY STUDY: PP.5.185
Author(s) -
S.G. Chrysant,
Michael Melino,
Víctor Fernández,
J Lee,
Reinilde Heyrman
Publication year - 2010
Publication title -
journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.249
H-Index - 172
eISSN - 1473-5598
pISSN - 0263-6352
DOI - 10.1097/01.hjh.0000378509.72582.91
Subject(s) - medicine , hydrochlorothiazide , olmesartan , clinical endpoint , placebo , randomization , combination therapy , urology , gastroenterology , clinical trial , blood pressure , alternative medicine , pathology